Article Versions Notes

Si Y, Zhang Y, Guan J-S, Ngo HG, Totoro A, Singh AP, Chen K, Xu Y, Yang ES, Zhou L, et al. Anti-CD47 Monoclonal Antibody–Drug Conjugate: A Targeted Therapy to Treat Triple-Negative Breast Cancers. Vaccines. 2021; 9(8):882. https://doi.org/10.3390/vaccines9080882

Si, Yingnan, Ya Zhang, Jia-Shiung Guan, Hanh Giai Ngo, Angela Totoro, Ajeet Pal Singh, Kai Chen, Yuanxin Xu, Eddy S. Yang, Lufang Zhou, and et al. 2021. "Anti-CD47 Monoclonal Antibody–Drug Conjugate: A Targeted Therapy to Treat Triple-Negative Breast Cancers" Vaccines 9, no. 8: 882. https://doi.org/10.3390/vaccines9080882

Si, Y., Zhang, Y., Guan, J.-S., Ngo, H. G., Totoro, A., Singh, A. P., Chen, K., Xu, Y., Yang, E. S., Zhou, L., Liu, R., & Liu, X. (2021). Anti-CD47 Monoclonal Antibody–Drug Conjugate: A Targeted Therapy to Treat Triple-Negative Breast Cancers. Vaccines, 9(8), 882. https://doi.org/10.3390/vaccines9080882